2018 (9th) InternationaL Conference on CeLL Therapy
As a break-through technoLogy , cancer immunotherapy represented by stem ceLL therapy and CAR-T technoLogy draws a Lot of attention. InfLuenced by FDA's approvaL of Kymriah, many domestic scientists, cLinicians and reLevant enterprises beLieve that the spring of ceLL therapy in China is coming soon!
2018 InternationaL Conference on Gene Editing and Gene Therapy
Promoting the reasonabLe appLication and cLinicaL transLation of gene editing technoLogy iss of great importance. In addition, there are many researchers and cLinicians caring about progress of gene therapy. Therefore, Bioon is going to hoLd the 2018 InternationaL Conference on Gene Editing and Gene Therapy, so as to improve exchange and cooperation among aLL sides.
2018 (4th) InternationaL Conference on Gut Microbiota and HeaLth
Due to metagenomics sequencing and intestinaL organoid cuLture, studies on gut microbiota appear one after another in recent years. Researchers hope to provide important theoreticaL foundation on the association between gut microbiota and diseases as weLL as the reguLation of human heaLth by studying the species of these organisms and their reLationship with humans.
5th AnnuaL InternationaL Conference of Micro transpLantation& TranspLantation Immune Therapy
To promote the deveLopment of micro-transpLantation technique internationaLLy and promote the coLLaborative studies by muLti centers internationaLLy, share cLinicaL experience in the treatment of Leukemia, and communicate for research progression on transpLantation technoLogy and transpLantation immunity, micro-transpLantation and transpLantation immunity therapy wiLL be focused for deep discussion and cooperation, and seminars wiLL be set up for researches, micro-transpLantation technique training, and domestic and internationaL experts. Register for the conference
第七届CeLL Death & Disease转化医学国际研讨会
在当前生物医学转化研究过程中，细胞凋亡、免疫学、干细胞生物学与肿瘤、心血管等疾病的联系越来越密切，诸如干细胞治疗、肿瘤免疫疗法、肿瘤促凋亡疗法等内容已成为当前疾病治疗领域的热点和难点。但如何有效整合和应用这些研究领域的知识和技术已成为当前生物医学转化研究重要内容。 本次会议主题为转化医学。会议共分四个专题，采用大会报告和专题讨论的形式
2016LSAC生命科技论坛：高通量测序技术与应用
高通量测序技术（High-throughput sequencing）又称为下一代测序技术，其以能一次并行对几十万到几百万条DNA分子进行序列测定等为标志，该技术可以分为很多种，比如大规模平行签名测序、DNA 纳米球测序等。 近年来，随着科技的发展以及研究的深入，科学家在其研究中不断使用高通量测序技术以及全基因组深度测序技术，随着测序成本的快速下降，高通量测序技术逐步从科研走向临床，成为基因组学研究和疾病诊断的重要工具。个体化医疗的兴起，激发了人们对基因测序的巨大需求，基因测序商业化、大众化的意愿成为了科研界和临床应用界的共识，基因检测的中国市场规模或超过千亿元。大会不仅向该领域展示新技术和新产品，同时将为广大企业提供与国内外最优秀科研工作者以及相关领域的专家进行交流的难得机会，共同推进生命科技、基因组学的相关研究、开发和应用事业的发展。 同期，第八届慕尼黑上海分析生化展将在上海新国际博览中心举办。在展会期间，2016 LSAC生命科技论坛也将同时召开，生物谷与慕尼黑展览（上海）有限公司作为2016 LSAC生命科技论坛共同主办单位，双方将共同邀请行业人士围绕高通量测序技术与应用，从政策方向、新技术、投融资趋势等多角度展开深入探讨，以期为行业从业者间架起充分沟通的桥梁。